GVAX vs. Placebo for MDS/AML After Allo HSCT

NCT01773395 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

123

Enrollment

OTHER

Sponsor class

Stopped Recommendation by the Data and Safety Monitoring Board due to efficacy concerns

Conditions

Myelodysplastic Syndrome
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia

Interventions

BIOLOGICAL: GVAX
BIOLOGICAL: Placebo Vaccine
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplant
DRUG: Busulfan
DRUG: Fludarabine
DRUG: Tacrolimus
DRUG: Methotrexate

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]